Pharmacist hypertension management using an electronic health record-based approach

Authors

Kristin K. Soreide, Henry Ford HealthFollow
Octavia Solomon, Henry Ford HealthFollow
Nada M. Farhat, Henry Ford HealthFollow
Sarah Kolander, Henry Ford HealthFollow
Terry Gottschall, Henry Ford HealthFollow
Diane L. George, Henry Ford HealthFollow
Edward G. Szandzik, Henry Ford HealthFollow
James S. Kalus, Henry Ford HealthFollow
Emily Thomas, Henry Ford HealthFollow

Recommended Citation

Soreide KK, Solomon O, Farhat NM, Kolander S, Gottschall T, George DL, Szandzik EG, Kalus JS, and Thomas E. Pharmacist hypertension management using an electronic health record-based approach. Am J Manag Care 2022; 28(4):e121-e125.

Document Type

Article

Publication Date

4-1-2022

Publication Title

The American journal of managed care

Abstract

OBJECTIVES: To evaluate the impact of the chronic medication optimization pharmacist (CMOP) program on blood pressure (BP) control and time to goal compared with usual care in the ambulatory care setting.

STUDY DESIGN: This was a retrospective cohort study that included patients from June 2018 to June 2020 who were seen in an ambulatory care clinic for hypertension management.

METHODS: Patients aged 18 to 80 years were divided into 2 cohorts based on hypertension management by usual care or the CMOP program. Patients were enrolled in the CMOP program either by referral or identification via a data analytics tool. The primary outcome assessed the proportion of patients within BP goal (< 140/90 mm Hg) at 3 months. Secondary outcomes assessed the proportion of patients within goal at 6 months, time and number of visits to goal, and adherence (CMOP cohort only).

RESULTS: The primary end point demonstrated a greater proportion of patients within goal in the CMOP cohort compared with usual care (69.4% vs 42.3%; P < .001). The CMOP cohort also displayed a greater proportion of patients achieving goal within 6 months (75.7% vs 60.4%; P = .014) and faster time to goal (42.99 vs 63.12 days; P = .002), but more visits (1.67 vs 1.18; P = .001). Lastly, adherence improved from 50.4% to 72.1% in the patients with a documented adherence assessment in the pharmacist group (P = .03).

CONCLUSIONS: The pharmacist intervention improved BP control in a primarily African American patient population compared with usual care. Future studies should assess the sustainability of this intervention.

Medical Subject Headings

Antihypertensive Agents; Blood Pressure; Electronic Health Records; Humans; Hypertension; Pharmacists; Retrospective Studies

PubMed ID

35420749

Volume

28

Issue

4

First Page

121

Last Page

121